Trenbolone Enanthate 200 mg Cygnus ( injectieflacon )

Description

Trenbolone Enanthate 200 mg Cygnus ( injectieflacon ) — trenbolone enanthate from Cygnus ( injectieflacon ) at 200 mg. The long-ester trenbolone: 7-day half-life enables 2×/week injection schedule. Slower onset than acetate; allow 2–3 weeks for full effects to develop.

Key Benefits

• Same receptor action as tren acetate — long ester for less pinning
• Twice-weekly injections produce flatter plasma than acetate EOD
• Cycle length 12–14 weeks (vs ace 8–10) exploits ester stability
• Cleaner PIP than acetate — cleaner injection experience
• Same side-effect burden as ace — not a “softer” tren
• Each unit dosed at 200 mg — see Recommended Dosage below for protocol-specific intake

Recommended Dosage

Research dosing: 200–400 mg/week split Mon/Thu. Steady-state requires 4–5 weeks of consistent dosing. Cycles 12–14 weeks to exploit the stable pharmacokinetic profile.

How It Works

19-nor trenbolone esterified to enanthoic acid. At the AR identical to acetate — ester changes only release kinetics, not biological activity. Progestagenic potential unchanged. Nutrient-partitioning profile unchanged.

Pharmacokinetics

Plasma half-life approximately 7 days. Twice-weekly pinning gives flat serum levels. Post-cycle clearance slower than acetate: wait 14 days after last pin before starting SERM-based PCT.

Cycle & Stacking Guide

Recomp and off-season strength cycles 12–14 weeks. Pair test E 400 mg/week + tren E 300 mg/week. Still requires caber, still demands bloodwork and sleep discipline. Not a beginner compound.

Manufacturer Notes

Cygnus ( injectieflacon ) is a mid-tier pharmaceutical producer with consistent formulation standards. Batch-specific documentation available on request.

Storage & Handling

Store upright at 15–25 °C in the original box, protected from light and moisture. Oil-based injectables are shelf-stable for the duration printed on the vial when kept at controlled room temperature. Do not refrigerate — cold thickens the carrier oil and makes drawing/injecting harder. Keep out of reach of children. For research and educational purposes only.